- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ultrasound diagnoses gout
Researchers have found a way to use ultrasound as a diagnostic tool for gout. The noninvasive modality could serve as a potential supplement to blood, urine, and joint fluid tests, which don't always provide a definitive diagnosis.
Researchers have found a way to use ultrasound as a diagnostic tool for gout. The noninvasive modality could serve as a potential supplement to blood, urine, and joint fluid tests, which don't always provide a definitive diagnosis.
Gout is a form of arthritis caused by uric acid crystals deposited on the connective tissue of joints, particularly small joints like the toes and fingers. Attacks of gout come and go, often with long symptom-free periods in between attacks. Left untreated, the uric acid crystals may grow into large, solid tophi. Screening options for gout include tests that look for excess uric acid in blood and urine, but levels may not be unusually high if crystals have already formed. Joint fluid samples may detect crystals, but sampling joint fluid can be painful. And none of these tests is definitive
The study was published in Rheumatology on April 27 by Dr. Ralf G. Thiele and Dr. Naomi Schlesinger in the rheumatology division of the University of Medicine and Dentistry of New Jersey. They studied ultrasound exams of 37 joints from 23 patients with confirmed cases of gout. They also studied ultrasound exams of 33 joints from 23 randomly selected patients with other rheumatic conditions as controls.
In 92% of the joints with gout, the researchers found an irregular hyperechoic band, called the double contour sign, over the edge of the cartilage. None of the control exams showed this sign.
Tophaceous material was also visible in all the ultrasound exams of gout patients' toes and fingers as hypo- or hyperechoic inhomogeneous material surrounded by a small anechoic rim. None of the controls showed these signs of tophi.
Erosion in the soft tissue of the joints next to tophaceous material was seen in 65% of toe joints with gout and 25% of finger joints with gout. One control patient with psoriatic arthritis showed similar signs of erosion in a toe joint.
The researchers concluded that ultrasound could reliably detect the deposition of urate crystals on cartilage as well as tophi and erosions typical of gout.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.
